ETHAN - ET for Male BC
ETHAN - ET for Male BC
Recruiting · NCT05501704 · Registry updated 2026-08-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ETHAN - ET for Male BC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, hormone receptor-positive breast cancer, male breast carcinoma, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-08-24 | NCT05501704 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
| Jose Pablo Leone | 1 |
| Translational Breast Cancer Research Consortium | 19 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 133 |
| Georgetown University Medical Center | Washington D.C. | United States | 62 |
| M. D. Anderson Cancer Center at University of Texas | Houston | United States | 2 |
| Mayo Clinic | Rochester | United States | 664 |
| Mayo Clinical Hospital Florida | Jacksonville | United States | 2 |
| UNC Lineberger Comprehensive Cancer Center | Chapel Hill | United States | 243 |
| University of Pennsylvania, Abramson Cancer Center | Philadelphia | United States | 12 |
| University of Pittsburgh Cancer Institute | Pittsburgh | United States | 1 |
| Vanderbilt Cancer Center | Nashville | United States | 2 |